Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Torrent Pharmaceuticals
Pharma
Lilly-Innovent, Dizal, bispecific ADC—Fierce Pharma Asia
China approved a first-in-class weight loss drug. Dizal won FDA approval. Biokin's BMS-partnered bispecific ADC celebrates a phase 3 win.
Angus Liu
Jul 10, 2025 5:20pm
Torrent Pharma wraps India's JB Pharma into its fold for $1.4B
Jul 1, 2025 11:43am
Big Pharma deal spree, China plans and more—Fierce Pharma Asia
Jan 5, 2024 8:44am
FDA slams trio of Indian drugmakers with Form 483 filings
Jan 3, 2024 9:40am
BMS, China reimbursement update, CAR-T hold—Fierce Pharma Asia
Dec 15, 2023 5:15am
FDA hits Torrent Pharma with a Form 483, citing 5 observations
Dec 13, 2023 10:31am
